Medtech Archives - Page 91 of 98 - Life Sciences Times

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

June 4, 2025

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

June 3, 2025

bluebird bio Acquired by Carlyle and SK Capital, Eyes Rapid Expansion Under New Leadership

June 2, 2025

THIS WEEK'S STORIES

TriSalus Life Sciences Names David B. Patience as New Chief Financial Officer

May 30, 2025

ZOLL and Simon’s Heart Donate AEDs to 32 Youth Organizations Nationwide in Honor of CPR and AED Awareness Week

June 4, 2025

Bambusa Therapeutics Doses First Subject in Phase 1 Trial of Novel Bispecific Antibody BBT002, Gains FDA Clearance for BBT001 IND

May 31, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medtech

Gore Launches 0.5 mL Silicone-Free Plunger for Ophthalmic Pre-Filled Syringes

ZOLL and Simon’s Heart Donate AEDs to 32 Youth Organizations Nationwide in Honor of CPR and AED Awareness Week

Muse Launches Athena Headband, Ushering in AI-Powered Sleep and Brain Health Diagnostics

Kopin Advances NeuralDisplay™ Prototype with Breakthrough Hardware and Software Milestones

America’s Family Doctors Adopts healow Genie to Enhance Patient Engagement and Care Coordination

Most Read

Ontario Brain Injury Association Warns of Hidden Dangers in Surviving Opioid Overdoses

Canid Raises $10 Million to Modernize Pediatric Vaccine Management and Reduce Burden on Independent Practices

Cyberattacks Disrupt Patient Care in Nearly 1 in 5 Healthcare Organizations, Omega Systems Report Finds

Gore Launches 0.5 mL Silicone-Free Plunger for Ophthalmic Pre-Filled Syringes

EDITOR PICKS

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

bluebird bio Acquired by Carlyle and SK Capital, Eyes Rapid Expansion Under New Leadership

THIS WEEK'S STORIES

TriSalus Life Sciences Names David B. Patience as New Chief Financial Officer

ZOLL and Simon’s Heart Donate AEDs to 32 Youth Organizations Nationwide in Honor of CPR and AED Awareness Week

Bambusa Therapeutics Doses First Subject in Phase 1 Trial of Novel Bispecific Antibody BBT002, Gains FDA Clearance for BBT001 IND

POPULAR CATEGORY

ABOUT US

FOLLOW US